New hope for kids with relapsed blood cancer: experimental cell therapy shows promise
NCT ID NCT06508931
First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 30 times
Summary
This study tests a new treatment called MB-CART2019.1 in children and teens (ages 6 months to under 18) with B-cell cancers that came back or didn't respond to previous treatments. The therapy uses the patient's own immune cells, modified to attack cancer cells. The main goals are to see if the treatment can shrink tumors and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Robert Debré
ACTIVE_NOT_RECRUITINGParis, Boulevard Sérurier 48, 75019, France
-
IRCCS Ospedale Pediatrico Bambino Gesù
RECRUITINGRome, Piazza Sant Onofrio 4, 00165, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prinses Maxima Centrum
ACTIVE_NOT_RECRUITINGUtrecht, Heidelberglaan 25, Netherlands
-
Universitaetsklinikum Muenster (UKM) - Klinik fuer Kinder- und Jugendmedizin - Paediatrische Haematologie und Onkologie
ACTIVE_NOT_RECRUITINGMünster, Albert-Schweitzer-Campus 1, Gebaeude A1, 48129, Germany
Conditions
Explore the condition pages connected to this study.